Expression of the miR-302/367 cluster in glioblastoma cells suppresses tumorigenic gene expression patterns and abolishes transformation related phenotypes
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expression of the miR-302/367 cluster in glioblastoma cells suppresses tumorigenic gene expression patterns and abolishes transformation related phenotypes
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 137, Issue 10, Pages 2296-2309
Publisher
Wiley
Online
2015-05-20
DOI
10.1002/ijc.29606
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Solid Tumor Differentiation Therapy – Is It Possible?
- (2015) Filemon Dela cruz et al. Oncotarget
- Drug Resistance via Feedback Activation of Stat3 in Oncogene-Addicted Cancer Cells
- (2014) Ho-June Lee et al. CANCER CELL
- Premature Termination of Reprogramming In Vivo Leads to Cancer Development through Altered Epigenetic Regulation
- (2014) Kotaro Ohnishi et al. CELL
- Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells
- (2014) Mario L. Suvà et al. CELL
- Resistance of Cancer Cells to Targeted Therapies Through the Activation of Compensating Signaling Loops
- (2014) Viktoria Manstein et al. Current Signal Transduction Therapy
- STAT3 Induction of miR-146b Forms a Feedback Loop to Inhibit the NF- B to IL-6 Signaling Axis and STAT3-Driven Cancer Phenotypes
- (2014) M. Xiang et al. Science Signaling
- Genome-wide Chromatin State Transitions Associated with Developmental and Environmental Cues
- (2013) Jiang Zhu et al. CELL
- Epigenetics of cellular reprogramming
- (2013) Raga Krishnakumar et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Function of oncogenes in cancer development: a changing paradigm
- (2013) Carolina Vicente-Dueñas et al. EMBO JOURNAL
- Reprogramming in vivo produces teratomas and iPS cells with totipotency features
- (2013) María Abad et al. NATURE
- Chromatin dynamics during cellular reprogramming
- (2013) Effie Apostolou et al. NATURE
- Histone lysine demethylases as targets for anticancer therapy
- (2013) Jonas W. Højfeldt et al. NATURE REVIEWS DRUG DISCOVERY
- Epigenetic Reprogramming in Cancer
- (2013) M. L. Suva et al. SCIENCE
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- The use of small molecules in somatic-cell reprogramming
- (2013) Alexander J. Federation et al. TRENDS IN CELL BIOLOGY
- Mechanisms of acquired resistance to targeted cancer therapies
- (2012) Mark R Lackner et al. Future Oncology
- Reprogramming cancer cells: back to the future
- (2012) J-Y Lang et al. ONCOGENE
- Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming
- (2012) X Zhang et al. ONCOGENE
- Self-Renewal and Pluripotency Acquired through Somatic Reprogramming to Human Cancer Stem Cells
- (2012) Shogo Nagata et al. PLoS One
- Cancer stem cells and epithelial–mesenchymal transition: Concepts and molecular links
- (2012) Christina Scheel et al. SEMINARS IN CANCER BIOLOGY
- Jak/Stat3 Signaling Promotes Somatic Cell Reprogramming by Epigenetic Regulation
- (2012) Yong Tang et al. STEM CELLS
- A novel role of miR-302/367 in reprogramming
- (2011) Chih-Hao Kuo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A Blueprint for Advancing Genetics-Based Cancer Therapy
- (2011) William R. Sellers CELL
- Highly Efficient miRNA-Mediated Reprogramming of Mouse and Human Somatic Cells to Pluripotency
- (2011) Frederick Anokye-Danso et al. Cell Stem Cell
- Chromatin higher-order structures and gene regulation
- (2011) Guohong Li et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Essential role of Stat3 in PI3K-induced oncogenic transformation
- (2011) Jonathan R. Hart et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Embryonic stem cell-specific signatures in cancer: insights into genomic regulatory networks and implications for medicine
- (2011) Jonghwan Kim et al. Genome Medicine
- MicroRNA miR-302 Inhibits the Tumorigenecity of Human Pluripotent Stem Cells by Coordinate Suppression of the CDK2 and CDK4/6 Cell Cycle Pathways
- (2010) S.-L. Lin et al. CANCER RESEARCH
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Opposing microRNA families regulate self-renewal in mouse embryonic stem cells
- (2010) Collin Melton et al. NATURE
- U87MG Decoded: The Genomic Sequence of a Cytogenetically Aberrant Human Cancer Cell Line
- (2010) Michael James Clark et al. PLoS Genetics
- Embryonic stem cell markers expression in cancers
- (2009) Matthieu Schoenhals et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- STAT3 Is Required for Proliferation and Maintenance of Multipotency in Glioblastoma Stem Cells
- (2009) Maureen M. Sherry et al. STEM CELLS
- Embryonic Stem Cell-Specific miR302-367 Cluster: Human Gene Structure and Functional Characterization of Its Core Promoter
- (2008) A. Barroso-delJesus et al. MOLECULAR AND CELLULAR BIOLOGY
- An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors
- (2008) Ittai Ben-Porath et al. NATURE GENETICS
- Stat3 and c-Myc Genome-Wide Promoter Occupancy in Embryonic Stem Cells
- (2008) Benjamin L. Kidder et al. PLoS One
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started